Skip to content

end-tidal fraction of nitric oxide as a biomarker of the lung injury during one-lung ventilation.

end-tidal fraction of nitric oxide as a biomarker investigating the effect of different OLV strategies on the lung injury and inflammation response.

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015993
Enrollment
Unknown
Registered
2018-05-05
Start date
2017-10-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thoracic anesthesia

Interventions

Gold Standard:oxygenation index, positive x ray chest film, pulmonary artery incarceration pressure or no increase of left atrial pressure, clinical presentations
Index test:End-tidal&#32
of&#32
(ETNO)&#32
continuously&#32
ventilation

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Patient to scheduled to undergo lung resection, mediastinal tumour resection, or 3-incision oesophagectomy under general anaesthesia with double-lumen tube; 2) their one-lung ventilation time was expected to last more than 1 h; 3) ASA classification II or III.

Exclusion criteria

Exclusion criteria: 1) their body mass index (BMI) was greater than 35 kg/m2; 2) they smoked during the last 2 weeks; 3) they had asthma, chronic obstructive pulmonary disease (COPD) or other chronic lung disease and cannot suffer high mechanical stress during OLV; 4) vital capacity or forced expiratory volume in 1 s <50% of the predicted values in the lung function, 5) numbers of leukocytes less than 4.0 × 109/L or more than 10.0 × 109/L); 6) they had experienced acute lung injury or acute respiratory distress syndrome before surgery; 7) they had received mechanical ventilation within the last 30 days; 8) they were receiving systemic corticosteroid therapy, or intractable shock was considered; or 9) they failed to maintain oxygen saturation of pulse oximeter (SpO2) greater than 95% during two-lung ventilation and greater than 85% during OLV.

Design outcomes

Primary

MeasureTime frame
ETNO;SPE, SEN, ACC;

Countries

China

Contacts

Public ContactEnyou Li

The First Affiliated Hospital of Harbin Medical University

enyouli@sina.com+86 13845109928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026